(19)

(11)

EP 4 770 658 A1

(12)

(43) Date of publication: 08.07.2026 Bulletin 2026/28 (21) Application number: 24776074.7 (22) Date of filing: 30.08.2024

(51) International Patent Classification (IPC):  A61K 38/01(2006.01) A61K 38/57(2006.01) A61K 38/02(2006.01) A61P 1/00(2006.01) (52) Cooperative Patent Classification (CPC): A61K 38/57; A61K 2035/122; A61P 1/00; A61K 38/01; A61K 38/02 (86) International application number: PCT/US2024/044764 (87) International publication number: WO 2025/049974 (06.03.2025 Gazette 2025/10)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 01.09.2023 US 202363536325 P (71) Applicant: Eom Pharmaceuticals Inc. Montvale, New Jersey 07645 (US)	(72) Inventors: HIRSCHMAN, Shalom Z. Summit Ave Montvale, New Jersey 07645 (US) TARAPOREWALA, Irach B. Summit Ave Montvale, New Jersey 07645 (US) GOLDBERGER, Eli Summit Ave Montvale, New Jersey 07645 (US) (74) Representative: Tombling, Adrian George  Withers & Rogers LLP 2 London Bridge London SE1 9RA London SE1 9RA (GB)